MDMA or related drug-induced anxiety transtorno, including MDA is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxicação com MDMA or related drugs. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of MDMA or related drug intoxicação, including MDA. The amount and duration of MDMA or related drug uso must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental transtorno (e.g., an Anxiety and fear-related transtorno, a Depressive transtorno com prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the MDMA or related drug uso, if the symptoms persist for a substantial period of time after cessation of the MDMA or related drug uso, or if there is other evidence of a pre-existing primary mental transtorno com anxiety symptoms (e.g., a history of prior episodes not associated com MDMA or related drug uso).